Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and function of proteins.
Proteomics International was established in 2001, and is now recognised as a global leader in the field of proteomics. It operates from state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth, Western Australia.
Proteomics International is experienced in delivering quality, accurate results that help progress your research and business.
- Proteomics International is accredited for compliance with ISO/IEC 17025 and has held this accreditation since 2009.
- Proteomics International holds Research and Development accreditation to ISO/IEC 17025, together with the OECD Principles of Good Laboratory Practice, interpreted for the research setting. Proteomics International has held this accreditation since 2016. For further detail of Proteomics International’s scope of accreditation, please refer to the NATA website, using accreditation number 16838.
- Proteomics International has over 16 years of experience in analysing proteins and in the method development of quantitative assays.